Furthermore, the involvement of the homologous recombination DNA repair pathway, which is frequently affected by BRCA1 and BRCA2 mutations, further underscores the link between these genetic alterations and the development of ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.